0 Citations
0 Reads
Abstract 537: Is interrupting IGF1R signaling enough to overcome resistance to trastuzumab in HER2+ breast cancer models?.
Yuliang Sun
Nandini Dey
Max Hasmann
Pradip De
Brian Leyland Jones
Cancer Research, 73(8 Supplement), pp 537-537, 2013-4-15
Summary
--
Keywords
--
Institution
--
Select Groups
Select Contacts
swap_vert Order by date
Order by date Order by name